Laura Deacon

Of counsel, intellectual property

London

e:
laura.deacon@herbertsmith.com
t:

+44 20 7466 2045

Laura Deacon

Laura holds the position "Of Counsel" in the Intellectual Property Department. She has a wealth of experience across a broad range of intellectual property issues.

In contentious matters she has advised on litigation and disputes relating to pharmaceutical patents, patents relating to complex printing techniques, trade mark infringement, copyright infringement and licensing and telecommunications networks.

In the non-contentious area Laura has advised on the acquisition and disposal of major brands and other intellectual property rights in a broad range of business and industrial sectors.  She also advises on the licensing of all intellectual property rights including in relation to the nuclear and defence sectors. Laura also advises UK and international clients on issues relating to UK data privacy law.


Credentials

Contentious

  •  Roche and Genetics Institute in the multi-jurisdictional patent dispute relating to recombinant erythropoietin
  • AstraZeneca in a challenge to the validity of its patents relating to its combination inhaler treatment for asthma
  • Easynet Telecommunications in proceedings relating to the technical specifications of a pan-European fibre optic telecommunications network
  • BSkyB in proceedings before the Copyright Tribunal regarding the royalties payable to the PRS for the use of music in television broadcasts

Non-contentious

  • Fortune Brands on its acquisition of a number of major spirits and wine brands from Pernod Ricard on the completion of the takeover by Pernod Ricard of Allied Domecq
  • Department of Trade and Industry on various intellectual property issues arising from the reform of nuclear clean-up in the UK
  • Nuclear Decommissioning Agency on various intellectual property issues
  • ABF on its acquisition of the yeast business of Burns Philp & Co
  • PriceWaterhouseCoopers on the intellectual property issues relating to the establishment of the PriceWaterhouseCoopers network

Click here to close this page